A rapid, high-volume cervical screening project using self-sampling and isothermal PCR HPV testing
Objective: Rapid, high-volume screening programs are needed as part of cervical cancer prevention in China.
Methods: In a 5-day screening project in Inner Mongolia, 3345 women volunteered following a community awareness campaign, and self-swabbed to permit rapid HPV testing. Two AmpFire™ HPV detection systems (Atila Biosystems) were sufficient to provide pooled 15-HPV type data within an hour. HPV+ patients had same-day digital colposcopy (DC) performed by 1 of 6 physicians, using the EVA™ system (MobileODT). Digital images were obtained and, after biopsy of suspected lesions for later confirmatory diagnosis, women were treated immediately based on colposcopic impression. Suspected low- grade lesions were offered treatment with thermal ablation (Wisap), and suspected high-grade lesions were treated with LLETZ.
Results: Of 3345 women screened, 624 (18.7%) were HPV+. Of these, 88.5% HPV+ women underwent same-day colposcopy and 78 were treated. Later consensus histology results obtained on 197 women indicated 20 CIN2+, of whom 15 were detected and treated/referred at screening (10 by thermal ablation, 4 by LLETZ, 1 by referral).
Conclusions: Global control of cervical cancer will require both vaccination and screening of a huge number of women. This study illustrates a cervical screening strategy that can be used to screen-and-treat large numbers of women. HPV self-sampling facilitates high-volume screening. Specimens can be tested rapidly, promoting minimal loss-to-follow-up.
Specifically, the AmpFire™ system used in this study is highly portable, simple, rapid (92 specimens per 65 min per unit), and economical. Visual triage can be performed on HPV+ women with a portable digital colposcope that provides magnification, lighting, and a recorded image. Diagnosis and appropriate treatment remain the most subjective elements. The digital image is under study for deep-learning based automated evaluation that could assist the management decision, either by itself or combined with HPV typing.
[The Identification of Acinetobacter baumannii Blood Isolates by MALDI-TOF MS, ARDRA and blaOXA-51-like Gene-Specific Real-Time PCR]
The Acinetobacter calcoaceticus-Acinetobacter baumannii (Acb) complex consists of phenotypically very similar nosocomial species; A.baumannii, Acinetobacter nosocomialis, Acinetobacter pittii, Acinetobacter seifertii and Acinetobacter djikshoorniae and one environmental species A.calcoaceticus. The rapid and accurate identification of the members of Acb complex is critical as these nosocomial pathogens can show differences in antimicrobial susceptibility and clinical outcomes.
The conventional phenotypic methods are slow, unreliable and less efficient for the differentiation of Acb complex species, including the A.baumannii species within the Acb complex. Although various molecular methods are available, such as amplified ribosomal DNA restriction analysis (ARDRA) and blaOXA-51-like gene specific PCR, they are usually inconvenient for the routine diagnostic laboratories. Recently, matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) offers an opportunity for rapid, cost-effective and convenient bacterial identification in routine diagnostic procedures conducted in clinical laboratory. In this study, we aimed to evaluate the diagnosis performance of MALDI-TOF MS system to identify blood isolates of A.baumannii. A total of 180 nonduplicate carbapenem resistant Acb complex (strain numbers; TR1-TR60) and A.baumannii (TR61-TR180) blood isolates were collected from the intensive care units of the three university hospitals in Turkey from January 2016 to December 2016.
All isolates were evaluated by using blaOXA-51-like gene specific real time (Rt-PCR) analysis, ARDRA (restriction enzymes-AluI, CfoI, MboI, MspI, RsaI) method and MALDI-TOF MS (VITEK® MS, bioMérieux, France) system. All the strains except TR10, TR31, TR35 and TR52 were identified as A.baumannii by ARDRA method. Out of 177 of all the isolates, presence of blaOXA-51-like gene was found except for TR10, TR31 and TR52 isolates. However, TR31 without the presence of blaOXA-51-like gene was identified as A.pittii using the ARDRA. Totally 176 isolates which were identified as A.baumannii by both of the methods, ARDRA and Rt-PCR- blaOXA-51-like, were accepted as a reference for the evaluation of the diagnosis performance capacity of the MALDI-TOF MS. Overall, for all 176 isolates tested, the sensitivity obtained with the MALDI-TOF MS were 99.4% with 75% specificity.
The accuracy value of the method was determined as 98.9% for the identification of A.baumannii to the species level. MALDI-TOF MS is increasingly used in diagnostic microbiology for the routine identification of bacteria to the genus, species or subspecies level with high rates of sensitivity and specificity. In future, by expanding the database, MALDI-TOF MS system would possibly become the ideal method for routine diagnostic laboratories that could potentially identify more species and even determine some characteristics of antimicrobial resistance and virulence determinants.
Evaluation of SARS-CoV-2 IgG antibody response in PCR positive patients: Comparison of nine tests in relation to clinical data
SARS-CoV-2 antibody tests are available in various formats, detecting different viral target proteins and antibody subclasses. The specificity and sensitivity of SARS-CoV-2 antibody tests are known to vary and very few studies have addressed the performance of these tests in COVID-19 patient groups at different time points. We here compared the sensitivity and specificity of seven commercial (SNIBE, Epitope, Euroimmun, Roche, Abbott, DiaSorin, Biosensor) and two in-house LIPS assays (LIPS N and LIPS S-RBD) IgG/total Ab tests in serum samples from 97 COVID-19 patients and 100 controls, and correlated the results with the patients’ clinical data and the time-point the test was performed. We found a remarkable variation in the sensitivity of antibody tests with the following performance: LIPS N (91.8%), Epitope (85.6%), Abbott and in-house LIPS S-RBD (both 84.5%), Roche (83.5%), Euroimmun (82.5%), DiaSorin (81.4%), SNIBE (70.1%), and Biosensor (64.9%).
The overall agreement between the tests was between 71-95%, whereas the specificity of all tests was within 98-100%. The correlation with patients’ clinical symptoms score ranged from strongest in LIPS N (ρ = 0.41; p<0.001) to nonsignificant in LIPS S-RBD. Furthermore, the time of testing since symptom onset had an impact on the sensitivity of some tests. Our study highlights the importance to consider clinical symptoms, time of testing, and using more than one viral antigen in SARS-CoV-2 antibody testing. Our results suggest that some antibody tests are more sensitive for the detection of antibodies in early stage and asymptomatic patients, which may explain the contradictory results of previous studies and should be taken into consideration in clinical practice and epidemiological studies.
Human Lung Cancer PCR Primer Library |
|||
HLUCPL-I | Real Time Primers | 1 set | EUR 657.6 |
Human Schwann Cell PCR Primer Library |
|||
HSCH-I | Real Time Primers | 1 set | EUR 657.6 |
0.2ML CLEAR STRIP CAPS FOR REAL TIME PCR |
|||
PCR-2CP-RT-C | CORNING | 125/pk | EUR 267.6 |
Description: PCR Plates & Tubes; PCR Strip Tubes and Strip Caps - Axygen |
Novel Coronavirus COVID-19 (2019-nCoV) Real Time RT-PCR Kit |
|||
RR-0478-02 | Liferiver | 25 tests/kit | EUR 1189.2 |
Description: Novel Coronavirus (2019-nCoV) Real Time RT-PCR Kit is used for the qualitative detection of a novel coronavirus, which was identified in 2019 at Wuhan City, Hubei Province, China, in upper respiratory tract specimens (nasopharyngeal extracts, deep cough sputum, etc.) and lower respiratory tract specimens (alveoli irrigation fluid, etc.) by real time PCR systems. |
AzuraQuant cDNA Synthesis Kit - 100 Reactions |
|||
AZ-1996 | Real Time Primers | 100 Reactions | EUR 446.4 |
AzuraQuant cDNA Synthesis Kit - 25 Reactions |
|||
AZ-1995 | Real Time Primers | 25 Reactions | EUR 183.6 |
Axygen Polyester ultra clear sealing film for real time PCR |
|||
AXY2152 | Scientific Laboratory Supplies | PK100 | EUR 382.8 |
Eztime Real - time PCRPremix 2x,Taqman |
|||
FYT105-100P | Yeastern Biotech | 100 Preps 1.25 ml | Ask for price |
Eco 48 Real Time PCR system including software and loading dock |
|||
MOL6348 | Scientific Laboratory Supplies | EACH | EUR 18466.8 |
Eztime Real - time PCRPremix 2x,SYBR Green |
|||
FYT103-100P | Yeastern Biotech | 100 Preps 1.25 ml | Ask for price |
Eztime Real - time PCRPremix 2x,SYBR Green |
|||
FYT103-400P | Yeastern Biotech | 400 Preps 1.25 ml x 4 | Ask for price |
Eztime Real - time PCRPremix 2x,Taqman, ROX |
|||
FYT105-400P | Yeastern Biotech | 400 Preps 1.25 ml x 4 | Ask for price |
Eztime Real - time PCRPremix 2x,Taqman, ROX |
|||
FYT106-100P | Yeastern Biotech | 100 Preps 1.25 ml | Ask for price |
Eztime Real - time PCRPremix 2x,SYBRGreen , ROX |
|||
FYT104-100P | Yeastern Biotech | 100 Preps 1.25 ml | Ask for price |
Eztime Real - time PCRPremix 2x,SYBRGreen , ROX |
|||
FYT104-400P | Yeastern Biotech | 400 Preps 1.25 ml x 4 | Ask for price |
hsa-mir-521 Real-time RT-PCR Detection Kit |
|||
20-abx097600 | Abbexa |
|
|
Green Dye One Step qRT-PCR Master Mix For Quantitative Real Time PCR With ROX Dye |
|||
MB1004-100Reactions | BosterBio | 100 Reactions | EUR 392.4 |
dsGreen for Real-Time PCR, 100×, 2 mL |
|||
61010 | Lumiprobe | 2 mL | EUR 435.6 |
Novel Coronavirus COVID-19 (2019-nCoV) Real Time Multiplex RT-PCR Kit (Detection for 3 Genes ) |
|||
RR-0479-02 | Liferiver | 25 tests/kit | EUR 469.56 |
Description: Novel Coronavirus (2019-nCoV) Real Time Multiplex RT-PCR Kit is used for the qualitative detection of a novel coronavirus, which was identified in 2019 at Wuhan City, Hubei Province, China, in upper respiratory tract specimens (nasopharyngeal extracts, deep cough sputum, etc.) and lower respiratory tract specimens (alveoli irrigation fluid, etc.) by real time PCR systems. It detects N gene, E gene and RdRp gene of 2019-nCoV. RR-0479-02 has been also approverd by CFDA for emergency use and is WHO standard. |
Azura PureView 1 Kb DNA Ladder - 100 Lanes |
|||
AZ-1101 | Real Time Primers | 100 Lanes | EUR 140.4 |
Azura PureView 1 Kb DNA Ladder - 500 Lanes |
|||
AZ-1105 | Real Time Primers | 500 Lanes | EUR 277.2 |
Azura PureView 1 Kb DNA Ladder - 1000 Lanes |
|||
AZ-1105-2 | Real Time Primers | 1000 Lanes | EUR 326.4 |
Azura PureView 250bp DNA Ladder - 100 Lanes |
|||
AZ-1121 | Real Time Primers | 100 Lanes | EUR 140.4 |
Azura PureView 250bp DNA Ladder - 500 Lanes |
|||
AZ-1125 | Real Time Primers | 500 Lanes | EUR 277.2 |
Azura PureView 250bp DNA Ladder - 1000 Lanes |
|||
AZ-1125-2 | Real Time Primers | 1000 Lanes | EUR 326.4 |
Azura PureView 100bp DNA Ladder - 100 Lanes |
|||
AZ-1131 | Real Time Primers | 100 Lanes | EUR 140.4 |
Azura PureView 100bp DNA Ladder - 500 Lanes |
|||
AZ-1135 | Real Time Primers | 500 Lanes | EUR 277.2 |
Azura PureView 100bp DNA Ladder - 1000 Lanes |
|||
AZ-1135-2 | Real Time Primers | 1000 Lanes | EUR 326.4 |
Azura PureView 50bp DNA Ladder - 100 Lanes |
|||
AZ-1151 | Real Time Primers | 100 Lanes | EUR 140.4 |
Azura PureView 50bp DNA Ladder - 500 Lanes |
|||
AZ-1155 | Real Time Primers | 500 Lanes | EUR 277.2 |
Azura PureView 50bp DNA Ladder - 1000 Lanes |
|||
AZ-1155-2 | Real Time Primers | 1000 Lanes | EUR 326.4 |
AzuraView GreenFast qPCR Blue Mix Lo Rox - 200 Rxn |
|||
AZ-2301 | Real Time Primers | 200 Rxn | EUR 214.8 |
AzuraView GreenFast qPCR Blue Mix Lo Rox - 500 Rxn |
|||
AZ-2305 | Real Time Primers | 500 Rxn | EUR 384 |
AzuraView GreenFast qPCR Blue Mix Lo Rox - 2000 Rxn |
|||
AZ-2320 | Real Time Primers | 2000 Rxn | EUR 1195.2 |
AzuraView GreenFast qPCR Blue Mix Lo Rox - 5000 Rxn |
|||
AZ-2325 | Real Time Primers | 5000 Rxn | EUR 2817.6 |
AzuraView GreenFast qPCR Blue Mix Hi Rox - 200 Rxn |
|||
AZ-2401 | Real Time Primers | 200 Rxn | EUR 214.8 |
AzuraView GreenFast qPCR Blue Mix Hi Rox - 500 Rxn |
|||
AZ-2405 | Real Time Primers | 500 Rxn | EUR 384 |
AzuraView GreenFast qPCR Blue Mix Hi Rox - 2000 Rxn |
|||
AZ-2420 | Real Time Primers | 2000 Rxn | EUR 1195.2 |
AzuraView GreenFast qPCR Blue Mix Hi Rox - 5000 Rxn |
|||
AZ-2421 | Real Time Primers | 5000 Rxn | EUR 2817.6 |
Mouse Gdnf Signaling Primer Library |
|||
MGDNF-I | Real Time Primers | 1 set | EUR 657.6 |
Mouse Glucose Metabolism Primer Library |
|||
MGLM-I | Real Time Primers | 1 set | EUR 657.6 |
Mouse Hippo Signaling Primer Library |
|||
MHPO-I | Real Time Primers | 1 set | EUR 657.6 |
Mouse Hypoxia Signaling Primer Library |
|||
MHYP-I | Real Time Primers | 1 set | EUR 657.6 |
Mouse Notch Signaling Primer Library |
|||
MNOT-I | Real Time Primers | 1 set | EUR 657.6 |
Mouse Neurotransmitter Signaling Primer Library |
|||
MNTS-I | Real Time Primers | 1 set | EUR 657.6 |
Mouse Integrin Signaling Primer Library |
|||
MINT-I | Real Time Primers | 1 set | EUR 891.6 |
Mouse Oxidative Stress Primer Library |
|||
MOSL-I | Real Time Primers | 1 set | EUR 657.6 |
Mouse Oncogene Primer Library |
|||
MONC-I | Real Time Primers | 1 set | EUR 657.6 |
Mouse Apoptosis Primer Library |
|||
MPA-I | Real Time Primers | 1 set | EUR 540 |
Mouse Ras Signaling Primer Library |
|||
MRAS-I | Real Time Primers | 1 set | EUR 657.6 |
Mouse T-Cell Receptor Signaling Primer Library |
|||
MTCR-I | Real Time Primers | 1 set | EUR 657.6 |
Mouse TGF Beta Signaling Primer Library |
|||
MTGFB-I | Real Time Primers | 1 set | EUR 657.6 |
Mouse Tumor Invasion/Metastasis Primer Library |
|||
MTIM-I | Real Time Primers | 1 set | EUR 540 |
Mouse Tumor Immunity Primer Library |
|||
MTIMU-I | Real Time Primers | 1 set | EUR 657.6 |
Mouse p53 Signaling Primer Library |
|||
MTPS-I | Real Time Primers | 1 set | EUR 540 |
Mouse WNT Signaling Primer Library |
|||
MWNT-I | Real Time Primers | 1 set | EUR 657.6 |
Mouse Toll-like Receptor Signaling Primer Library |
|||
newitem | Real Time Primers | 1 set | EUR 657.6 |
Mouse PI3K-AKT Signaling Primer Library |
|||
MAKT-I | Real Time Primers | 1 set | EUR 657.6 |
Mouse Angiogenesis Primer Library |
|||
MAPL-I | Real Time Primers | 1 set | EUR 540 |
Mouse Adherin - Tight Junction Primer Library |
|||
MATJ-I | Real Time Primers | 1 set | EUR 657.6 |
Mouse Autophagy Primer Library |
|||
MATPL-I | Real Time Primers | 1 set | EUR 540 |
Mouse Bdnf Signaling Primer Library |
|||
MBDNF-I | Real Time Primers | 1 set | EUR 657.6 |
Mouse BMP Signaling Primer Library |
|||
MBMP-I | Real Time Primers | 1 set | EUR 657.6 |
Mouse Cytokine Primer Library I |
|||
MCA-I | Real Time Primers | 1 set | EUR 540 |
Mouse Cytokine Primer Library II |
|||
MCA-II | Real Time Primers | 1 set | EUR 540 |
Mouse Cell Cycle Primer Library |
|||
MCC-I | Real Time Primers | 1 set | EUR 540 |
Mouse Cytokine and Chemokine Receptor Primer Library |
|||
MCCR-I | Real Time Primers | 1 set | EUR 774 |
Mouse CREB Signaling Primer Library |
|||
MCREB-I | Real Time Primers | 1 set | EUR 657.6 |
Mouse DNA Damage Signaling Primer Library |
|||
MDDS-I | Real Time Primers | 1 set | EUR 657.6 |
Mouse DNA Repair Primer Library I |
|||
MDRL-I | Real Time Primers | 1 set | EUR 774 |
Mouse DNA Repair Primer Library II |
|||
MDRL-II | Real Time Primers | 1 set | EUR 774 |
Mouse Adipogenesis Primer Library |
|||
MADG-I | Real Time Primers | 1 set | EUR 657.6 |
Mouse EGFR Signaling Primer Library |
|||
MEGFR-I | Real Time Primers | 1 set | EUR 657.6 |
Mouse Epithelial-Mesenchymal Transition Primer Library |
|||
MEMT-I | Real Time Primers | 1 set | EUR 657.6 |
Mouse Estrogen Receptor Signaling Library |
|||
MESR-I | Real Time Primers | 1 set | EUR 774 |
Mouse Fatty Liver Signaling Primer Library |
|||
MFTL-I | Real Time Primers | 1 set | EUR 657.6 |
Mouse Jak/Stat Signaling Primer Library |
|||
MJAK-I | Real Time Primers | 1 set | EUR 774 |
Mouse MAP Kinase Signaling Primer Library |
|||
MMAP-I | Real Time Primers | 1 set | EUR 657.6 |
Mouse Myeloid Derived Suppressor Cell Primer Library |
|||
MMDSC-I | Real Time Primers | 1 set | EUR 657.6 |
Mouse NFKappaB Primer Library |
|||
MNFKB-I | Real Time Primers | 1 set | EUR 540 |
Human DNA Repair Primer Library I |
|||
HDRL-I | Real Time Primers | 1 set | EUR 657.6 |
Human DNA Repair Primer Library II |
|||
HDRL-II | Real Time Primers | 1 set | EUR 657.6 |
Human Drug Transporter I Primer Library |
|||
HDTP-I | Real Time Primers | 1 set | EUR 657.6 |
Human Drug Detoxication I |
|||
HDTX-I | Real Time Primers | 1 set | EUR 657.6 |
Human Drug Detoxication II |
|||
HDTX-II | Real Time Primers | 1 set | EUR 774 |
Human EGFR Signaling Primer Library |
|||
HEGFR-I | Real Time Primers | 1 set | EUR 657.6 |
Human Epithelial Mesenchymal Transition Primer Library |
|||
HEMT-I | Real Time Primers | 1 set | EUR 657.6 |
Human Endothelial Cell Primer Library |
|||
HEND-I | Real Time Primers | 1 set | EUR 657.6 |
Human ERBB Signaling Primer Library |
|||
HERBB-I | Real Time Primers | 1 set | EUR 657.6 |
Human Estrogen Signaling Primer Library |
|||
HESR-I | Real Time Primers | 1 set | EUR 774 |
Human Focal Adhesion Signaling Primer Library |
|||
HFCA-I | Real Time Primers | 1 set | EUR 657.6 |
Human FGF Receptor Signaling Primer Library |
|||
HFGF-I | Real Time Primers | 1 set | EUR 774 |
Human Fatty Acid and Lipid Metabolism Primer Library |
|||
HFLM-I | Real Time Primers | 1 set | EUR 657.6 |
Human Gastric Cancer Primer Library |
|||
HGCPL-I | Real Time Primers | 1 set | EUR 657.6 |
Human GDNF Signaling Primer Library |
|||
HGDNF-I | Real Time Primers | 1 set | EUR 657.6 |
Human Glucose Metabolism Primer Library |
|||
HGLM-I | Real Time Primers | 1 set | EUR 540 |
Human G-Protein Coupled Receptor Signaling Primer Library |
|||
HGPCR-I | Real Time Primers | 1 set | EUR 657.6 |
Human Hedgehog Signaling Primer Library |
|||
HHOG-I | Real Time Primers | 1 set | EUR 774 |
Human Homeobox Gene Primer Library |
|||
HHOX-I | Real Time Primers | 1 set | EUR 774 |
Human Hippo Signaling Primer Pathway |
|||
HHPO-I | Real Time Primers | 1 set | EUR 657.6 |
[Evaluation of SARS-CoV-2 PCR Positive Cases in the Pediatric Emergency Department]
In December 2019, a previously unknown type of coronavirus was detected in China and named as “severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)”. The World Health Organization has named the SARS-CoV-2 related as coronavirus disease-2019 (COVID-19) and declared it as a pandemic. There is a limited data about the COVID-19 disease for the pediatric patients. In this study, it was aimed to evaluate the epidemiological, clinical, laboratory and radiologic findings, treatment and clinical outcomes of patients admitted to the pediatric emergency department with the suspicion of COVID-19. Between March 11 and June 16, 2020, patients aged between 1 month-18 years admitted to the pediatric emergency department and who have an indication for sampling for the polymerase chain reaction (PCR) method with the suspicion of COVID-19 according to the current guidelines published by the Ministry of Health were included in the study. The demographic characteristics, symptoms, durations and the history of contact with the suspected/definite COVID-19 cases were questioned in the patients with positive results. Physical examination, laboratory and imaging data of the patients were recorded. According to clinical severity, patients were divided into five groups.

mhealthinfo
Treatment methods, ward/intensive care unit admission, length of stay at hospital, and prognosis were recorded. Of the 237 patients included in the study, 45 (18.9%) of the samples were positive and 192 (81.1%) were negative. There was a history of contact with COVID-19 positive case in 38 (85.6%) of COVID-19 PCR positive patients. The mean time for onset of symptoms after contact was 3.5 ± 1.7 days. Twenty-one of the patients (46.6%) were asymptomatic and the most common symptom was fever (34.1%) and cough (27.3%). Of the patients whose laboratory tests were requested, lymphopenia wasdetected in 50% and 52.3% of procalcitonin, 23.5% of C-reactive protein and 64.7% of D-dimer values were found to be high.
Chest radiography was obtained from 45.4% of the patients; 90.0% were evaluated as normal, bronchovascular change, pleural effusion and consolidation were detected in one of each (5.0%) patient. Thorax computed tomography (CT) was obtained from 4 (9.0%) patients. One patient had normal CT findings, two patients had consolidation, one patient had peripheral ground-glass appearance and one patient had pleural effusion. Antibiotics were started in 38.6% of the patients and the most commonly used antibiotic was azithromycin (34.1%). Oseltamivir was started in one (2.3%) patient, and 10 (24.7%) patients were treated with hydroxychloroquine.
There were no serious and critical cases according to the clinical severity. Pediatric patients constitute a small part of COVID-19 individuals in the community, and a significant part of them are asymptomatic, and patients who are symptomatic present with a mild clinic. In our study, most of the patients had a history of contact with COVID-19 positive cases, therefore, it should be questioned when evaluating a pediatric patient. There were no specific findings for COVID-19 positive patients in terms of laboratory and radiology.
Test productt 2 |
|||
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa | National Diagnostics | 0 | Ask for price |
Diogenes Kit |
|||
NAT1000 | National Diagnostics | 1KIT | EUR 270 |
Hydrogen Peroxide Assay Kit |
|||
NAT1002 | National Diagnostics | 1KIT | EUR 308.4 |
ProtoBlock System |
|||
NAT1004 | National Diagnostics | 1KIT | EUR 122.4 |
450ML PBS 10X |
|||
NAT1006 | National Diagnostics | 450ML | EUR 96 |
4L PBS 10X |
|||
NAT1008 | National Diagnostics | 4L | EUR 238.8 |
ProtoGlow ECL 200ml Kit |
|||
NAT1010 | National Diagnostics | EACH | EUR 354 |
ProtoGlow ECL 500ml Kit |
|||
NAT1012 | National Diagnostics | EACH | EUR 627.6 |
100G Acrylamide |
|||
NAT1014 | National Diagnostics | 100G | EUR 120 |
500G Acrylamide |
|||
NAT1016 | National Diagnostics | 500G | EUR 261.6 |
1KG Acrylamide |
|||
NAT1018 | National Diagnostics | 1KG | EUR 412.8 |
25G AquaPor LE |
|||
NAT1020 | National Diagnostics | 25G | EUR 132 |
100G AquaPor LE GTAC |
|||
NAT1022 | National Diagnostics | 100G | EUR 250.8 |
500G AquaPor LE GTAC |
|||
NAT1024 | National Diagnostics | 500G | EUR 878.4 |
25G AquaPor ES |
|||
NAT1026 | National Diagnostics | 25G | EUR 152.4 |
100G AquaPor ES |
|||
NAT1028 | National Diagnostics | 100G | EUR 350.4 |
25G AquaPor LM |
|||
NAT1030 | National Diagnostics | 25G | EUR 288 |
100G AquaPor LM |
|||
NAT1032 | National Diagnostics | 100G | EUR 860.4 |
25G AquaPor HR |
|||
NAT1034 | National Diagnostics | 25G | EUR 236.4 |
100G AquaPor HR |
|||
NAT1036 | National Diagnostics | 100G | EUR 592.8 |
25G AquaPor 3:1 |
|||
NAT1038 | National Diagnostics | 25G | EUR 250.8 |
100G AquaPor 3:1 |
|||
NAT1040 | National Diagnostics | 100G | EUR 570 |
25G Bis (Methylene Bis-Acrylamide) |
|||
NAT1042 | National Diagnostics | 25G | EUR 100.8 |
25G DATD Ultrapure |
|||
NAT1044 | National Diagnostics | 25G | EUR 168 |
250G Glycine |
|||
NAT1046 | National Diagnostics | 250G | EUR 94.8 |
1KG Glycine Ultrapure |
|||
NAT1048 | National Diagnostics | 1KG | EUR 128.4 |
250G Tris |
|||
NAT1050 | National Diagnostics | 250G | EUR 102 |
1KG Tris Ultrapure |
|||
NAT1052 | National Diagnostics | 1KG | EUR 177.6 |
100G Tricine |
|||
NAT1054 | National Diagnostics | 100G | EUR 120 |
100G Ion Exchange Resin (mixed bed) |
|||
NAT1056 | National Diagnostics | 100G | EUR 96 |
25G Riboflavin |
|||
NAT1058 | National Diagnostics | 25G | EUR 96 |
25ML TEMED |
|||
NAT1060 | National Diagnostics | 25ML | EUR 99.6 |
25G Ammonium Persulfate |
|||
NAT1062 | National Diagnostics | 25G | EUR 96 |
100G Ammonium Persulfate |
|||
NAT1064 | National Diagnostics | 100G | EUR 118.8 |
1G Dithiothreitol (DTT) |
|||
NAT1066 | National Diagnostics | 1G | EUR 103.2 |
5G Dithiothreitol (DTT) |
|||
NAT1068 | National Diagnostics | 5G | EUR 183.6 |
50ML 2-Mercaptoethanol |
|||
NAT1070 | National Diagnostics | 50ML | EUR 112.8 |
100G SDS Ultrapure |
|||
NAT1072 | National Diagnostics | 100G | EUR 111.6 |
1KG SDS Ultrapure |
|||
NAT1074 | National Diagnostics | 1KG | EUR 457.2 |
250G Urea |
|||
NAT1076 | National Diagnostics | 250G | EUR 98.4 |
1KG Urea |
|||
NAT1078 | National Diagnostics | 1KG | EUR 138 |
450ML Glycerol Ultrapure |
|||
NAT1080 | National Diagnostics | 450ML | EUR 132 |
200ML Tween 20 Ultrapure |
|||
NAT1082 | National Diagnostics | 200ML | EUR 132 |
1L Tween 20 |
|||
NAT1084 | National Diagnostics | 1L | EUR 169.2 |
200ML Formamide |
|||
NAT1086 | National Diagnostics | 200ML | EUR 111.6 |
500ML Boric Acid |
|||
NAT1088 | National Diagnostics | 500ML | EUR 103.2 |
100G EDTA |
|||
NAT1090 | National Diagnostics | 100G | EUR 94.8 |
500G EDTA |
|||
NAT1092 | National Diagnostics | 500G | EUR 177.6 |
GelDry Film 11 X 12 cm |
|||
NAT1094 | National Diagnostics | PK50 | EUR 100.8 |
25ML Formamide CE |
|||
NAT1096 | National Diagnostics | 25ML | Ask for price |
25ML Glass Bond |
|||
NAT1098 | National Diagnostics | 25ML | EUR 158.4 |
450ML Glass Free |
|||
NAT1100 | National Diagnostics | 450ML | EUR 196.8 |
GelDry Film 22.5 X 22.5 cm |
|||
NAT1102 | National Diagnostics | PK50 | EUR 130.8 |
1L DEPC Treated Water |
|||
NAT1104 | National Diagnostics | 1L | EUR 120 |
Sterling Rapid Silver Stain Kit |
|||
NAT1106 | National Diagnostics | 1KIT | EUR 265.2 |
1L ProtoBlue Safe |
|||
NAT1108 | National Diagnostics | 1L | EUR 159.6 |
4L ProtoBlue Safe |
|||
NAT1110 | National Diagnostics | 4L | EUR 282 |
1L ProtoStain Blue |
|||
NAT1112 | National Diagnostics | 1L | EUR 164.4 |
25ML Nuclistain |
|||
NAT1114 | National Diagnostics | 25ML | EUR 128.4 |
450ML AcrylaGel 30% |
|||
NAT1116 | National Diagnostics | 450ML | EUR 128.4 |
1L AcrylaGel 30% |
|||
NAT1118 | National Diagnostics | 1L | EUR 177.6 |
450ML Bis-AcrylaGel 2% |
|||
NAT1120 | National Diagnostics | 450ML | EUR 98.4 |
1L Bis-AcrylaGel 2% |
|||
NAT1122 | National Diagnostics | 1L | EUR 111.6 |
450ML UreaGel 29:1 Concentrate |
|||
NAT1124 | National Diagnostics | 450ML | EUR 133.2 |
1L UreaGel 29:1 Concentrate |
|||
NAT1126 | National Diagnostics | 1L | EUR 183.6 |
UreaGel 29:1 System 1L Kit |
|||
NAT1128 | National Diagnostics | EACH | EUR 171.6 |
UreaGel 29:1 System 2.2L Kit |
|||
NAT1130 | National Diagnostics | EACH | EUR 253.2 |
450ML SequaGel UreaGel Concentrate |
|||
NAT1132 | National Diagnostics | 450ML | EUR 126 |
1L SequaGel UreaGel Concentrate |
|||
NAT1134 | National Diagnostics | 1L | EUR 160.8 |
SequaGel Sequencing System 1L Kit |
|||
NAT1136 | National Diagnostics | 1KIT | EUR 171.6 |
SequaGel Sequencing System 2.2L Kit |
|||
NAT1138 | National Diagnostics | EACH | EUR 253.2 |
100ML SequaGel Buffer |
|||
NAT1140 | National Diagnostics | 100ML | EUR 80.4 |
200ML SequaGel UreaGel Buffer |
|||
NAT1142 | National Diagnostics | 200ML | EUR 84 |
450ML SequaGel UreaGel-6 |
|||
NAT1144 | National Diagnostics | 450ML | EUR 115.2 |
1L SequaGel UreaGel-6 |
|||
NAT1146 | National Diagnostics | 1L | EUR 151.2 |
450ML SequaGel UreaGel-8 |
|||
NAT1148 | National Diagnostics | 450ML | EUR 115.2 |
1L SequaGel UreaGel-8 |
|||
NAT1150 | National Diagnostics | 1L | EUR 151.2 |
450ML SequaGel UreaGel Diluent |
|||
NAT1152 | National Diagnostics | 450ML | EUR 90 |
1L SequaGel UreaGel Diluent |
|||
NAT1154 | National Diagnostics | 1L | EUR 103.2 |
90ML SequaGel Complete Buffer |
|||
NAT1156 | National Diagnostics | 90ML | EUR 79.2 |
200ML SequaGel UreaGel Complete Buffer |
|||
NAT1158 | National Diagnostics | 200ML | EUR 85.2 |